WO2002016578A3 - Secreted proteins and methods of using same - Google Patents
Secreted proteins and methods of using same Download PDFInfo
- Publication number
- WO2002016578A3 WO2002016578A3 PCT/US2001/022598 US0122598W WO0216578A3 WO 2002016578 A3 WO2002016578 A3 WO 2002016578A3 US 0122598 W US0122598 W US 0122598W WO 0216578 A3 WO0216578 A3 WO 0216578A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- same
- secreted proteins
- useful
- nucleic acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001284651A AU2001284651A1 (en) | 2000-08-24 | 2001-08-17 | Secreted proteins and methods of using same |
US10/343,953 US20030212258A1 (en) | 2001-08-17 | 2001-08-17 | Novel secreted proteins and methods of using same |
EP01963725A EP1313765A2 (en) | 2000-08-24 | 2001-08-17 | Secreted proteins and methods of using same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22769700P | 2000-08-24 | 2000-08-24 | |
US60/227,697 | 2000-08-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002016578A2 WO2002016578A2 (en) | 2002-02-28 |
WO2002016578A3 true WO2002016578A3 (en) | 2003-01-16 |
Family
ID=22854119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/022598 WO2002016578A2 (en) | 2000-08-24 | 2001-08-17 | Secreted proteins and methods of using same |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1313765A2 (en) |
AU (1) | AU2001284651A1 (en) |
WO (1) | WO2002016578A2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8008332B2 (en) | 2006-05-31 | 2011-08-30 | Takeda San Diego, Inc. | Substituted indazoles as glucokinase activators |
US8034822B2 (en) | 2006-03-08 | 2011-10-11 | Takeda San Diego, Inc. | Glucokinase activators |
US8124617B2 (en) | 2005-09-01 | 2012-02-28 | Takeda San Diego, Inc. | Imidazopyridine compounds |
US8163779B2 (en) | 2006-12-20 | 2012-04-24 | Takeda San Diego, Inc. | Glucokinase activators |
US8173645B2 (en) | 2007-03-21 | 2012-05-08 | Takeda San Diego, Inc. | Glucokinase activators |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997007198A2 (en) * | 1995-08-11 | 1997-02-27 | Genetics Institute, Inc. | Dna sequences and secreted proteins encoded thereby |
WO1999056763A1 (en) * | 1998-05-07 | 1999-11-11 | The Regents Of The University Of California | Use of neglected target tissue antigens in modulation of immune responses |
WO2001079454A1 (en) * | 2000-04-13 | 2001-10-25 | Smithkline Beecham Corporation | Novel compounds |
-
2001
- 2001-08-17 EP EP01963725A patent/EP1313765A2/en not_active Withdrawn
- 2001-08-17 WO PCT/US2001/022598 patent/WO2002016578A2/en not_active Application Discontinuation
- 2001-08-17 AU AU2001284651A patent/AU2001284651A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997007198A2 (en) * | 1995-08-11 | 1997-02-27 | Genetics Institute, Inc. | Dna sequences and secreted proteins encoded thereby |
WO1999056763A1 (en) * | 1998-05-07 | 1999-11-11 | The Regents Of The University Of California | Use of neglected target tissue antigens in modulation of immune responses |
WO2001079454A1 (en) * | 2000-04-13 | 2001-10-25 | Smithkline Beecham Corporation | Novel compounds |
Non-Patent Citations (3)
Title |
---|
DATABASE EMBL [online] 7 January 1998 (1998-01-07), LAMERDIN, J.E. ET AL.: "Homo sapiens chromosome 19, cosmid R26624 (LLNLR-226B12), complete sequence.", XP002199809, Database accession no. AC003967 * |
KLEIN R D ET AL: "SELECTION FOR GENES ENCODING SECRETED PROTEINS AND RECEPTORS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 93, no. 14, 9 July 1996 (1996-07-09), pages 7108 - 7113, XP002061411, ISSN: 0027-8424 * |
YOKOYAMA-KOBAYASHI M ET AL: "A signal sequence detection system using secreted protease activity as an indicator", GENE, ELSEVIER BIOMEDICAL PRESS. AMSTERDAM, NL, vol. 163, no. 2, 3 October 1995 (1995-10-03), pages 193 - 196, XP004041983, ISSN: 0378-1119 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8124617B2 (en) | 2005-09-01 | 2012-02-28 | Takeda San Diego, Inc. | Imidazopyridine compounds |
US8034822B2 (en) | 2006-03-08 | 2011-10-11 | Takeda San Diego, Inc. | Glucokinase activators |
US8008332B2 (en) | 2006-05-31 | 2011-08-30 | Takeda San Diego, Inc. | Substituted indazoles as glucokinase activators |
US8394843B2 (en) | 2006-05-31 | 2013-03-12 | Takeda California, Inc. | Substituted isoindoles as glucokinase activators |
US8163779B2 (en) | 2006-12-20 | 2012-04-24 | Takeda San Diego, Inc. | Glucokinase activators |
US8173645B2 (en) | 2007-03-21 | 2012-05-08 | Takeda San Diego, Inc. | Glucokinase activators |
Also Published As
Publication number | Publication date |
---|---|
AU2001284651A1 (en) | 2002-03-04 |
WO2002016578A2 (en) | 2002-02-28 |
EP1313765A2 (en) | 2003-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002014358A3 (en) | Novel secreted proteins and their uses | |
WO2002008277A3 (en) | Nucleic acids, vectors, host cells, polypeptides, and uses thereof | |
WO1999031236A3 (en) | EXTENDED cDNAs FOR SECRETED PROTEINS | |
WO2001000806A3 (en) | Dna's encoding proteins with signal peptides | |
WO2000006736A3 (en) | Nucleic acids and proteins from group b streptococcus | |
WO2002059315A3 (en) | Human nucleic acids and polypeptides and methods of use thereof | |
WO2001032882A3 (en) | Nucleic acids and proteins from group b streptococcus | |
WO2002032939A3 (en) | Secreted proteins and their uses | |
WO2001087978A3 (en) | Human abc transporter and its use | |
WO2002026801A3 (en) | Secreted proteins and their uses | |
WO2002048361A3 (en) | Novel secreted proteins and their uses | |
WO2002016578A3 (en) | Secreted proteins and methods of using same | |
WO2001092493A3 (en) | 21956 and 25856, human aminopeptidases and uses thereof | |
AU2001238064A1 (en) | 18477, a human protein kinase and uses therefor | |
WO2002090500A3 (en) | Novel human proteins, polynucleotides encoding them and methods of using the same | |
WO2002012475A3 (en) | C1q-related factor, homologous polypeptides and therapeutic uses thereof | |
EP1529843A3 (en) | Novel secreted proteins and their uses | |
WO2003029778A3 (en) | Novel secreted proteins and their uses | |
WO2002074960A3 (en) | 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof | |
WO2004013281A3 (en) | Novel proteins and their uses | |
WO2002046408A3 (en) | Human proteins, polynucleotides encoding them and methods of using the same | |
WO2002048187A3 (en) | Secretion signal peptides, their dna sequences, expression vectors for eukaryotic cells that can be produced with the same, and use thereof for biotechnological production of proteins | |
WO2003083048A3 (en) | Novel secreted proteins and their uses | |
WO2004087886A3 (en) | Modified adenoviral e1a constructs and methods of use thereof | |
WO2002016579A3 (en) | Nucleic acids, vectors, host cells, polypeptides and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 10343953 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001963725 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001963725 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001963725 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |